ES2024508B3 - Forma de dosificacion para liberar un medicamento que comprende un componente regulador de solubilidad. - Google Patents
Forma de dosificacion para liberar un medicamento que comprende un componente regulador de solubilidad.Info
- Publication number
- ES2024508B3 ES2024508B3 ES87304209T ES87304209T ES2024508B3 ES 2024508 B3 ES2024508 B3 ES 2024508B3 ES 87304209 T ES87304209 T ES 87304209T ES 87304209 T ES87304209 T ES 87304209T ES 2024508 B3 ES2024508 B3 ES 2024508B3
- Authority
- ES
- Spain
- Prior art keywords
- release
- dosage form
- product including
- medicinal product
- regulator component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/874,961 US4755180A (en) | 1986-06-16 | 1986-06-16 | Dosage form comprising solubility regulating member |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2024508B3 true ES2024508B3 (es) | 1992-03-01 |
Family
ID=25364968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87304209T Expired - Lifetime ES2024508B3 (es) | 1986-06-16 | 1987-05-12 | Forma de dosificacion para liberar un medicamento que comprende un componente regulador de solubilidad. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4755180A (es) |
EP (1) | EP0254394B1 (es) |
JP (1) | JPH085777B2 (es) |
CA (1) | CA1283829C (es) |
DE (1) | DE3773442D1 (es) |
ES (1) | ES2024508B3 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286494A (en) * | 1986-07-02 | 1994-02-15 | Schering Aktiengesellschaft | Medicinal agents with sustained action |
US4871542A (en) * | 1987-04-30 | 1989-10-03 | Ferring Service Center, N.V. | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
US4994273A (en) * | 1987-11-02 | 1991-02-19 | Merck & Co., Inc. | Solubility modulated drug delivery device |
US4898734A (en) * | 1988-02-29 | 1990-02-06 | Massachusetts Institute Of Technology | Polymer composite for controlled release or membrane formation |
CA2001395C (en) * | 1988-10-26 | 1995-10-03 | Roy H. Hammerstedt | Noningestible separation barrier with plugged pores |
US5261870A (en) * | 1988-10-26 | 1993-11-16 | Biopore, Inc. | Separation barrier with plugged pores |
US5376383A (en) * | 1988-11-21 | 1994-12-27 | Merck & Co., Inc. | Method for enhancing the lowering of plasma-cholesterol levels |
US4997658A (en) * | 1988-11-21 | 1991-03-05 | Merck & Co., Inc. | Method for enhancing the lowering of plasma cholesterol levels |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
TW235239B (es) * | 1992-11-20 | 1994-12-01 | Pfizer | |
GB9626233D0 (en) * | 1996-12-18 | 1997-02-05 | Chawla Brinda P S | Medicament packaging and deliveery device |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
MXPA02006335A (es) | 1999-12-23 | 2002-12-13 | Pfizer Prod Inc | Forma de dosificacion de farmaco en capas impulsada por hidrogel. |
JP2005525299A (ja) * | 2001-09-14 | 2005-08-25 | スコラー インコーポレイテッド | アミノ酸調節性の長期放出投薬形態 |
US20070098784A1 (en) | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
JP5041651B2 (ja) * | 2001-09-28 | 2012-10-03 | ティーエヌティーギャンブル・インコーポレーテッド | 生物体成分の送達系 |
GB0130055D0 (en) | 2001-12-14 | 2002-02-06 | Technology Innovation Ltd | Medicament packaging |
SE0202365D0 (sv) * | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
DE602004028585D1 (de) | 2003-03-15 | 2010-09-23 | Brin Tech Internat Ltd | Verpackung für Arzneimittel |
US20050053669A1 (en) * | 2003-09-05 | 2005-03-10 | Boehringer Ingelheim International Gmbh | Administration form for the oral application of poorly soluble acidic and amphorteric drugs |
DE10341414A1 (de) * | 2003-09-05 | 2005-03-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe |
US20050175701A1 (en) * | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system |
US20060045891A1 (en) * | 2004-08-24 | 2006-03-02 | Lovalenti Phillip M | Density-matched suspension vehicles and pharmaceutical suspensions |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
DE602007009377D1 (de) | 2006-05-30 | 2010-11-04 | Intarcia Therapeutics Inc | Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem |
ES2398126T3 (es) | 2006-08-09 | 2013-03-13 | Intarcia Therapeutics, Inc | Sistemas de liberación osmótica y unidades de pistón |
MX2009011123A (es) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Formulaciones de suspensiones de peptidos insulinotropicos y sus usos. |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
NZ747990A (en) | 2009-09-28 | 2020-06-26 | Intarcia Therapeutics Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
USD741471S1 (en) * | 2013-10-01 | 2015-10-20 | John F. LaGratta | Cylindrical tablet having separable mating components |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
NZ738102A (en) | 2015-06-03 | 2024-02-23 | Intarcia Therapeutics Inc | Implant placement and removal systems |
TWI814219B (zh) | 2016-05-16 | 2023-09-01 | 美商因塔希亞治療公司 | 升糖素受體選擇性多肽和彼之使用方法 |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
US10835580B2 (en) | 2017-01-03 | 2020-11-17 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1815902A (en) * | 1927-07-16 | 1931-07-28 | Nat Aniline & Chem Co Inc | Device for administering medicaments |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4111201A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4236525A (en) * | 1978-11-22 | 1980-12-02 | Intermedics, Inc. | Multiple function lead assembly |
US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
US4320759A (en) * | 1980-04-28 | 1982-03-23 | Alza Corporation | Dispenser with diffuser |
US4326525A (en) * | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
WO1983003061A1 (en) * | 1982-03-04 | 1983-09-15 | Battelle Development Corp | Dual microcapsules |
FR2524311A1 (fr) * | 1982-04-05 | 1983-10-07 | Azalbert Gilles | Gelule compartimentee aux fins d'ingestions simultanees a effets differes |
US4553973A (en) * | 1982-07-12 | 1985-11-19 | Alza Corporation | Process for preparing osmotic device |
US4610686A (en) * | 1983-11-02 | 1986-09-09 | Alza Corporation | Controlled delivery of haloperidol by an osmotic delivery system |
-
1986
- 1986-06-16 US US06/874,961 patent/US4755180A/en not_active Expired - Fee Related
-
1987
- 1987-05-12 ES ES87304209T patent/ES2024508B3/es not_active Expired - Lifetime
- 1987-05-12 DE DE8787304209T patent/DE3773442D1/de not_active Expired - Fee Related
- 1987-05-12 EP EP87304209A patent/EP0254394B1/en not_active Expired - Lifetime
- 1987-05-25 CA CA000537910A patent/CA1283829C/en not_active Expired - Fee Related
- 1987-06-15 JP JP62148886A patent/JPH085777B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3773442D1 (de) | 1991-11-07 |
US4755180A (en) | 1988-07-05 |
JPS62298522A (ja) | 1987-12-25 |
CA1283829C (en) | 1991-05-07 |
EP0254394B1 (en) | 1991-10-02 |
EP0254394A1 (en) | 1988-01-27 |
JPH085777B2 (ja) | 1996-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2024508B3 (es) | Forma de dosificacion para liberar un medicamento que comprende un componente regulador de solubilidad. | |
PT86986A (pt) | Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments | |
FR2618673B1 (fr) | Formule medicamenteuse a liberation controlee | |
MX9207676A (es) | Metodo para preparar medicamentos de administracion oral, con recubrimiento enterico y que contienen compuestos inestables a los acidos. | |
MX171861B (es) | Composiciones medicinales acuosas que contienen un factor de crecimiento poli-peptidico y el metodo para estabilizar las mismas | |
ES513357A0 (es) | "un sistema terapeutico bajo la forma de un vendaje para administrar el medicamento". | |
ES526901A0 (es) | Procedimiento para la preparar una tableta farmaceutica para procurar una liberacion sostenidad de medicamento. | |
ES2017899A4 (es) | Derivados xantino que tienen actividad broncodilatadora, un proceso para la preparacion de ello y compuestos farmaceuticos que los contienen | |
IT1193552B (it) | Dispositivo per la somministrazione di medicinali a ruminanti | |
ES512362A0 (es) | Perfeccionamientos en un dispositivo para aumentar la seguridad de funcionamiento de un reloj duplicado. | |
MX9203559A (es) | Una forma de dosificacion para administrar clorofeniramina. | |
ES277103Y (es) | Envase bolsa para productos medicinales. | |
DE3880667T2 (de) | Ampulle zur gesteuerten verabreichung eines heilmittels. | |
FR2604902B1 (fr) | Compositions pharmaceutiques a liberation prolongee | |
PT90333A (pt) | Processo para a preparacao de uma vacina sintetica contra a febre aftosa | |
ES549632A0 (es) | Procedimiento para preparar un articulo de resina. | |
PT87186A (pt) | Imidazothiadiazine derivatives a process for preparing the same and their use as medicaments | |
ES1012701Y (es) | Dispositivo para dosificar un producto de tratamiento en un liquido que le circunda. | |
DE3781045T2 (de) | Antirheumatisches arzneimittel. | |
BE865369A (fr) | Medicament a base d'extrait de physarym | |
PT86642A (pt) | Arylthiadiazolylsulfonamides and derivatives a process for thir preparation and their use as medicaments | |
FI875325A0 (fi) | Bestraolningsanordning foer synbart ljus vid medicinal anvaendning. | |
ES1002166Y (es) | Recipiente para productos que desprenden gas | |
PT90059A (pt) | Processo para a preparacao de alcools aromaticos tio-substituidos uteis como produtos farmaceuticos | |
ES1000231Y (es) | Envase dispensador para productos cosmeticos en barra |